Cardiovascular Health Improvement Project

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity of Michigan

About this trial

The goal of this project is to establish a biobank of clinical information, DNA, plasma, and aortic tissue samples from patients with cardiovascular disease as well as healthy controls.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Any patient over the age of 18 who is able/willing to give informed consent

Patients <18 years of age with parental consent and assent (if assent is applicable for their age)

aortic pathology potentially due to a known or suspected inherited condition

Idiopathic aortic aneurysm

Disqualifiers

None

Trial population

Outpatient clinic

Trial design

Design model

Case-control

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

15,000 Participants
are grouped into 2 trial groups
Group A: Aortic Disease
Group B: Controls

Trial outcomes

Primary outcomes

1

Establishing a biobank of patients with Aortic Disease

Establish a biobank of blood, serum, plasma, tissue, and clinical data of patients with any form of aortic disease

Time frame
40 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.